AKT1 and triple-negative breast carcinoma: Moreover, it was found to significantly suppress the proliferation of triple-negative breast cancer (TNBC), which is known to be difficult to treat and has a poor prognosis, and cell apoptosis is promoted via the inhibition of signaling pathways such as PI3K/Akt [104].